CCCC
Price
$4.21
Change
+$0.34 (+8.79%)
Updated
Jun 12, 12:17 PM (EDT)
Capitalization
427.34M
61 days until earnings call
Intraday BUY SELL Signals
TARS
Price
$63.14
Change
+$0.53 (+0.85%)
Updated
Jun 12, 11:50 AM (EDT)
Capitalization
2.69B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs TARS

Header iconCCCC vs TARS Comparison
Open Charts CCCC vs TARSBanner chart's image
CCCC vs TARS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CCCC vs. TARS commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and TARS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 12, 2026
Stock price -- (CCCC: $3.87 vs. TARS: $62.61)
Brand notoriety: CCCC and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 74% vs. TARS: 61%
Market capitalization -- CCCC: $427.34M vs. TARS: $2.69B
CCCC [@Biotechnology] is valued at $427.34M. TARS’s [@Biotechnology] market capitalization is $2.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $112.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, TARS is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while TARS’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • TARS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than TARS.

Price Growth

CCCC (@Biotechnology) experienced а -7.31% price change this week, while TARS (@Biotechnology) price change was +3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.19%. For the same industry, the average monthly price growth was +87.05%, and the average quarterly price growth was +1971.74%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 12, 2026.

TARS is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-4.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARS($2.69B) has a higher market cap than CCCC($427M). CCCC YTD gains are higher at: 102.356 vs. TARS (-23.534). TARS has higher annual earnings (EBITDA): -33.82M vs. CCCC (-101.2M). TARS has more cash in the bank: 389M vs. CCCC (236M). CCCC has less debt than TARS: CCCC (58.4M) vs TARS (72.6M). TARS has higher revenues than CCCC: TARS (535M) vs CCCC (34.9M).
CCCCTARSCCCC / TARS
Capitalization427M2.69B16%
EBITDA-101.2M-33.82M299%
Gain YTD102.356-23.534-435%
P/E RatioN/AN/A-
Revenue34.9M535M7%
Total Cash236M389M61%
Total Debt58.4M72.6M80%
TECHNICAL ANALYSIS
Technical Analysis
CCCCTARS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
TARS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGGGX49.711.36
+2.81%
American Funds Intl Gr and Inc529-F-2
AVASX23.620.27
+1.16%
American Beacon Large Cap Value Adv
GEGCX19.82N/A
N/A
abrdn Emerging Markets C
MSEFX11.70N/A
N/A
iMGP Global Select Instl
HGXIX18.38N/A
N/A
Hartford Global Impact I

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-0.13%
AXON - CCCC
40%
Loosely correlated
-0.31%
CELC - CCCC
38%
Loosely correlated
+1.33%
REPL - CCCC
35%
Loosely correlated
+1.53%
WVE - CCCC
35%
Loosely correlated
+2.56%
ARRY - CCCC
35%
Loosely correlated
+9.00%
More